Works matching IS 25233548 AND DT 2022 AND VI 42 AND IP 9

Results: 10

PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.

Published in:

Cancer Communications, 2022, v. 42, n. 9, p. 848, doi. 10.1002/cac2.12341

By:

Dai, Weixing;
Xiang, Wenqiang;
Han, Lingyu;
Yuan, Zixu;
Wang, Renjie;
Ma, Yanlei;
Yang, Yongzhi;
Cai, Sanjun;
Xu, Ye;
Mo, Shaobo;
Li, Qingguo;
Cai, Guoxiang

Publication type:

Article

Nasopharyngeal carcinoma treatment paradigm after HK0501 – a potential way forward.

Published in:

Cancer Communications, 2022, v. 42, n. 9, p. 801, doi. 10.1002/cac2.12339

By:

Poh, Sharon S;
Wee, Joseph TS

Publication type:

Article

The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression.

Published in:

Cancer Communications, 2022, v. 42, n. 9, p. 868, doi. 10.1002/cac2.12334

By:

Yuan, Ye;
Wang, Li‐Hong;
Zhao, Xian‐Xian;
Wang, Jiao;
Zhang, Meng‐Si;
Ma, Qing‐Hua;
Wei, Sen;
Yan, Ze‐Xuan;
Cheng, Yue;
Chen, Xiao‐Qing;
Zou, Hong‐Bo;
Ge, Jia;
Wang, Yan;
Zhang, Xia;
Cui, You‐Hong;
Luo, Tao;
Bian, Xiu‐Wu

Publication type:

Article

p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases.

Published in:

Cancer Communications, 2022, v. 42, n. 9, p. 897, doi. 10.1002/cac2.12331

By:

Fajardo, Pilar;
Taskova, Maria;
Martín‐Serrano, Miguel A.;
Hansen, Jonas;
Slott, Sofie;
Jakobsen, Anna K.;
Wibom, Marie‐Louise;
Salegi, Beñat;
Muñoz, Alberto;
Barbachano, Antonio;
Sharma, Arpita;
Gubatan, John Mark;
Habtezion, Aida;
Sanz‐Ezquerro, Juan J.;
Astakhova, Kira;
Cuenda, Ana

Publication type:

Article

Antibody variable region engineering for improving cancer immunotherapy.

Published in:

Cancer Communications, 2022, v. 42, n. 9, p. 804, doi. 10.1002/cac2.12330

By:

Lou, Hantao;
Cao, Xuetao

Publication type:

Article

KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer.

Published in:

Cancer Communications, 2022, v. 42, n. 9, p. 828, doi. 10.1002/cac2.12327

By:

Liu, Chengming;
Zheng, Sufei;
Wang, Zhanyu;
Wang, Sihui;
Wang, Xinfeng;
Yang, Lu;
Xu, Haiyan;
Cao, Zheng;
Feng, Xiaoli;
Xue, Qi;
Wang, Yan;
Sun, Nan;
He, Jie

Publication type:

Article

Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis.

Published in:

Cancer Communications, 2022, v. 42, n. 9, p. 902, doi. 10.1002/cac2.12320

By:

Xu, Yan;
Song, Yanjun;
Liu, Xiaoyan;
Shi, Yuequan;
Liu, Yingxian;
Qian, Hao;
Gao, Xiaoxing;
Chen, Minjiang;
Pan, Ruili;
Zhao, Jing;
Zhong, Wei;
Wu, Wei;
Wang, Mengzhao

Publication type:

Article

Transcriptome‐wide association analysis identified candidate susceptibility genes for nasopharyngeal carcinoma.

Published in:

Cancer Communications, 2022, v. 42, n. 9, p. 887, doi. 10.1002/cac2.12317

By:

He, Yong‐Qiao;
Xue, Wen‐Qiong;
Li, Dan‐Hua;
Wang, Tong‐Min;
Mai, Zhi‐Ming;
Yang, Da‐Wei;
Deng, Chang‐Mi;
Liao, Ying;
Zhang, Wen‐Li;
Xiao, Ruo‐Wen;
Luo, Luting;
Diao, Hua;
Tong, Xiating;
Wu, Yanxia;
Zhang, Jiang‐Bo;
Zhou, Ting;
Li, Xi‐Zhao;
Zhang, Pei‐Fen;
Zheng, Xiao‐Hui;
Zhang, Shao‐Dan

Publication type:

Article

A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2.

Published in:

Cancer Communications, 2022, v. 42, n. 9, p. 892, doi. 10.1002/cac2.12292

By:

Vitale, Emanuele;
Sauta, Elisabetta;
Gugnoni, Mila;
Torricelli, Federica;
Manicardi, Veronica;
Ciarrocchi, Alessia

Publication type:

Article

Issue Information.

Published in:: Cancer Communications, 2022, v. 42, n. 9, p. 799, doi. 10.1002/cac2.12173
Publication type:: Article